BridgeBio Pharma
BBIO
$27.83
Share price
0.32%
Change (1 day)
103.44%
Change (1 year)
Categories
BridgeBio Pharma (BBIO) - Cash on Hand
Cash on Hand as of December 2023 : $0.43 B
According to BridgeBio Pharma
's latest financial reports the company has $0.43 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
BridgeBio Pharma - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.43 B | -7.85% |
| 2022-12-31 | $0.47 B | -43.59% |
| 2021-12-31 | $0.83 B | 37.81% |
| 2020-12-31 | $0.60 B | 11.19% |
| 2019-12-31 | $0.54 B | 25.2% |
| 2018-12-31 | $0.43 B | 374.03% |
| 2017-12-31 | $91.99 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $95.88 M | -77.95% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.82 M | -95.21% | 🇺🇸 USA |